Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

(2020) Lirong Zou et al.   NEW ENGLAND JOURNAL OF MEDICINE

On the origin and continuing evolution of SARS-CoV-2

(2020) Xiaolu Tang et al.   National Science Review

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

(2020) Lisheng Wang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Covid-19: FDA approves use of convalescent plasma to treat critically ill patients

(2020) Janice Hopkins Tanne   BMJ-British Medical Journal

Impact of recent and future climate change on vector-borne diseases

(2018) Cyril Caminade et al.   Annals of the New York Academy of Sciences

Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment

(2016) Shawn D. Keil et al.   TRANSFUSION

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro

(2016) Andrew P. Cap et al.   TRANSFUSION

Prophylaxis and Therapy for Chikungunya Virus Infection

(2009) Thérèse Couderc et al.   JOURNAL OF INFECTIOUS DISEASES

Global trends in emerging infectious diseases

(2008) Kate E. Jones et al.   NATURE